ArticleGlobal health & medicine2019

A novel HIV-1 protease inhibitor, GRL-044, has potent activity against various HIV-1s with an extremely high genetic barrier to the emergence of HIV-1 drug resistance.

Manabu Aoki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.